LogicBio Therapeutics, Inc.

2022 Q4 Form 10-Q Financial Statement

#000156459022037503 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.78M $59.58M
YoY Change -48.34% 84.55%
Cash & Equivalents $30.78M $59.58M
Short-Term Investments $0.00
Other Short-Term Assets $1.996M $985.0K
YoY Change 102.64% -21.83%
Inventory
Prepaid Expenses
Receivables $0.00 $119.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $32.78M $60.69M
YoY Change -45.99% 80.88%
LONG-TERM ASSETS
Property, Plant & Equipment $1.503M $6.879M
YoY Change -78.15% -9.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $622.0K $622.0K
YoY Change 0.0% 0.32%
Total Long-Term Assets $5.825M $7.501M
YoY Change -22.34% -9.19%
TOTAL ASSETS
Total Short-Term Assets $32.78M $60.69M
Total Long-Term Assets $5.825M $7.501M
Total Assets $38.60M $68.19M
YoY Change -43.39% 63.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.111M $903.0K
YoY Change 23.03% -13.17%
Accrued Expenses $2.321M $4.659M
YoY Change -50.18% 42.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.306M $3.291M
YoY Change 0.46% 202.2%
Total Short-Term Liabilities $16.43M $13.69M
YoY Change 20.04% 153.52%
LONG-TERM LIABILITIES
Long-Term Debt $2.626M $5.790M
YoY Change -54.65% -34.78%
Other Long-Term Liabilities $3.803M $9.942M
YoY Change -61.75% 89.73%
Total Long-Term Liabilities $2.626M $5.790M
YoY Change -54.65% -34.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.43M $13.69M
Total Long-Term Liabilities $2.626M $5.790M
Total Liabilities $22.86M $29.42M
YoY Change -22.3% 50.73%
SHAREHOLDERS EQUITY
Retained Earnings -$157.5M -$131.0M
YoY Change 20.27%
Common Stock $3.000K $3.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.74M $38.76M
YoY Change
Total Liabilities & Shareholders Equity $38.60M $68.19M
YoY Change -43.39% 63.09%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2021Q4 us-gaap Assets Current
AssetsCurrent
55666000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1335000
dei Entity Central Index Key
EntityCentralIndexKey
0001664106
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
65 Hayden Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
2nd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Lexington
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02421
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
245-0399
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32962733
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53480000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10639000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19583000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2626000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5006000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3725000
dei Entity Registrant Name
EntityRegistrantName
LogicBio Therapeutics, Inc.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1514975
dei Trading Symbol
TradingSymbol
LOGC
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
30000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2156000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
32776000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1503000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
622000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
622000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3700000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4571000
CY2022Q3 us-gaap Assets
Assets
38601000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2321000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3704000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1227000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3306000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3295000
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8360000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16433000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
13000
us-gaap Interest Expense
InterestExpense
591000
us-gaap Interest Expense
InterestExpense
824000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5775000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10213000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5775000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10185000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-396000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-814000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17481000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32962733
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32962733
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32952306
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32952306
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
173237000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157501000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140020000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
15739000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
30727000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38601000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62770000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3383000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170744000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8732000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10293000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8732000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15524000
us-gaap Operating Expenses
OperatingExpenses
33563000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17085000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30180000
us-gaap Net Income Loss
NetIncomeLoss
-30966000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5775000
CY2021Q3 us-gaap Interest Expense
InterestExpense
270000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2120000
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
001-38707
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1911000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
718000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9943000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
147000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3000
CY2022Q3 us-gaap Interest Expense
InterestExpense
176000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12081000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
12063000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5744000
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30780000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1996000
CY2021Q4 us-gaap Assets
Assets
62770000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1111000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2711000
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1092000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3729000
CY2022Q3 us-gaap Liabilities
Liabilities
22862000
CY2021Q4 us-gaap Liabilities
Liabilities
32043000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2717000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2717000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2120000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8732000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3383000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2717000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2717000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2120000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2120000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8732000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3383000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3383000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5051000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5051000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7806000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7806000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15524000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21482000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21482000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3410000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3410000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4257000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4257000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10293000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12081000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
8461000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
8461000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
12063000
us-gaap Operating Expenses
OperatingExpenses
25817000
us-gaap Operating Expenses
OperatingExpenses
25817000
us-gaap Operating Expenses
OperatingExpenses
33563000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5744000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9943000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17085000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30180000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
147000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
197000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
197000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
13000
CY2022Q3 us-gaap Interest Expense
InterestExpense
176000
CY2021Q3 us-gaap Interest Expense
InterestExpense
270000
us-gaap Interest Expense
InterestExpense
591000
us-gaap Interest Expense
InterestExpense
824000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-270000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-270000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-396000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-814000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5775000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10213000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17481000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30994000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30994000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5775000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10185000
us-gaap Net Income Loss
NetIncomeLoss
-17481000
us-gaap Net Income Loss
NetIncomeLoss
-17481000
us-gaap Net Income Loss
NetIncomeLoss
-30966000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32962733
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32962733
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32443960
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32443960
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32962221
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32962221
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32181912
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32181912
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5775000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10185000
us-gaap Net Income Loss
NetIncomeLoss
-17481000
us-gaap Net Income Loss
NetIncomeLoss
-30966000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5775000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10185000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17481000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30966000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
61427000
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
65000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
989000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-10282000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
54225000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52000
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
997000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10499000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44820000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
35000
CY2021Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
92000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1132000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10185000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38764000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30727000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
846000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6662000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24911000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
849000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5044000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20716000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
798000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15739000
us-gaap Profit Loss
ProfitLoss
-17481000
us-gaap Profit Loss
ProfitLoss
-30966000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
508000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
451000
us-gaap Share Based Compensation
ShareBasedCompensation
2493000
us-gaap Share Based Compensation
ShareBasedCompensation
3118000
logc Non Cash Interest Expense
NonCashInterestExpense
131000
logc Non Cash Interest Expense
NonCashInterestExpense
173000
logc Non Cash Lease Expense
NonCashLeaseExpense
836000
logc Non Cash Lease Expense
NonCashLeaseExpense
811000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-160000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1220000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-30000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-144000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
393000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
456000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2254000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
26000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4916000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10733000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20100000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13834000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
734000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-734000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
87000
logc Proceeds From At Market Common Stock Issuances
ProceedsFromAtMarketCommonStockIssuances
5098000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-2500000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1111000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4074000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22700000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3333000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1389000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
5555000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10494000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54102000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70697000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31402000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60203000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30780000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59581000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
622000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
622000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31402000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60203000
us-gaap Interest Paid Net
InterestPaidNet
460000
us-gaap Interest Paid Net
InterestPaidNet
651000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
48000
us-gaap Net Income Loss
NetIncomeLoss
-17481000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20100000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30780000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1648000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2289000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
665000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1341000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
74000
CY2022Q3 logc Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
2321000
CY2021Q4 logc Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
3704000
CY2022Q3 us-gaap Notes Payable
NotesPayable
5556000
CY2021Q4 us-gaap Notes Payable
NotesPayable
8055000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
46000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
93000
CY2022Q3 logc Debt Instrument Accretion Of Final Payment Fee
DebtInstrumentAccretionOfFinalPaymentFee
422000
CY2021Q4 logc Debt Instrument Accretion Of Final Payment Fee
DebtInstrumentAccretionOfFinalPaymentFee
339000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5932000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
8301000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3306000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3295000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2626000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5006000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
833000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5775000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5775000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10185000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10185000
us-gaap Net Income Loss
NetIncomeLoss
-17481000
us-gaap Net Income Loss
NetIncomeLoss
-17481000
us-gaap Net Income Loss
NetIncomeLoss
-30966000
us-gaap Net Income Loss
NetIncomeLoss
-30966000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32962733
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32962733
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32443960
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32443960
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32962221
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32962221
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32181912
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32181912
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
CY2022Q3 logc Lessee Operating Lease Liability Payments Due After Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree
0
CY2021Q4 logc Lessee Operating Lease Liability Payments Due After Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree
0
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4502000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5668000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
456000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
716000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4046000
CY2022Q3 logc Operating Lease Number Of Leases
OperatingLeaseNumberOfLeases
1
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
378000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
378000
us-gaap Operating Lease Cost
OperatingLeaseCost
1134000
us-gaap Operating Lease Cost
OperatingLeaseCost
1134000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
231000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
208000
us-gaap Variable Lease Cost
VariableLeaseCost
669000
us-gaap Variable Lease Cost
VariableLeaseCost
639000
CY2022Q3 us-gaap Lease Cost
LeaseCost
609000
CY2021Q3 us-gaap Lease Cost
LeaseCost
586000
us-gaap Lease Cost
LeaseCost
1803000
us-gaap Lease Cost
LeaseCost
1773000
us-gaap Operating Lease Payments
OperatingLeasePayments
1166000
us-gaap Operating Lease Payments
OperatingLeasePayments
385000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1335000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1227000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2711000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3725000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0760
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0760
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
396000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1562000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
1609000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
1609000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
1656000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
1656000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
841000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
841000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4952000

Files In Submission

Name View Source Status
0001564590-22-037503-index-headers.html Edgar Link pending
0001564590-22-037503-index.html Edgar Link pending
0001564590-22-037503.txt Edgar Link pending
0001564590-22-037503-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logc-10q_20220930.htm Edgar Link pending
logc-20220930.xsd Edgar Link pending
logc-ex102_132.htm Edgar Link pending
logc-ex311_9.htm Edgar Link pending
logc-ex312_6.htm Edgar Link pending
logc-ex321_8.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
logc-20220930_lab.xml Edgar Link unprocessable
logc-20220930_def.xml Edgar Link unprocessable
logc-20220930_pre.xml Edgar Link unprocessable
logc-20220930_cal.xml Edgar Link unprocessable
logc-10q_20220930_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable